相关实验视频

Updated: Sep 19, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

推进地幔细胞淋巴瘤风险评估:在移动目标中导航

Simone Ferrero¹, Simone Ragaini¹

¹Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.

Hematological oncology

|June 15, 2025

概括

膜细胞淋巴瘤 (MCL) 管理正在发展. TP53中断是关键的不良因素,最小残留疾病 (MRD) 监测提供了个性化的治疗适应,以获得更好的结果.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

膜细胞淋巴瘤 (MCL) 是一种具有异质临床行为的B细胞恶性瘤.
风险分层的进步区分了传统的MCL (cMCL) 与具有独特特征的非节点性MCL (nnMCL) 亚型.

研究的目的:

审查当前的预后因素和新兴的策略,用于地细胞淋巴瘤.
要突出TP53中断和最小残留疾病 (MRD) 监测在MCL管理中的作用.

主要方法:

对预后工具的审查,包括MIPI/MIPI-c,Ki-67和TP53突变/删除状态.
讨论新出现的基因组变化 (例如,17p删除,CDKN2A损失) 作为预后因素.
探索最小残留疾病 (MRD) 监测作为一个动态预后工具.

主要成果:

已确定TP53中断是与MCL的不良结果相关的主要不良因素.
新的基因组变化正在成为显著的预后指标.
最少残留疾病 (MRD) 监测显示了动态风险评估和治疗适应的潜力.

结论:

尽管有新的治疗方法,高风险的MCL的有效管理仍然具有挑战性.
整合分子预测因素,临床数据和MRD监测对于个性化的MCL治疗策略至关重要.
结合MRD监测的个性化治疗策略可能构成MCL管理的未来算法.

关键词:

这就是TP53的特点.生物标志物生物标志物地毯细胞淋巴瘤最少残留疾病的最小残留疾病.个性化医疗是个性化的医疗.风险评估风险评估风险评估

更多相关视频

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...